YZi Labs announces investment in regenerative medicine company Renewal Bio
Jinse Finance reported that YZi Labs has announced an investment in the regenerative medicine company Renewal Bio, marking YZi Labs' first biotechnology investment since expanding its investment scope in early 2025. Renewal Bio focuses on using its proprietary Stembroid™ platform to generate DNA-matched human cells and tissues from patients' own cells, aiming to address the global organ shortage crisis. This round of funding will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells for the treatment of leukemia and immune diseases, and support the expansion of laboratory infrastructure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Curvance completes $4 million strategic financing
A certain whale purchased 523,007 UNI through FalconX, worth $4.44 million.
